Efficacy and safety of atorvastatin compared to pravastatin in patients with hypercholesterolemia
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference18 articles.
1. Anderson KM, Castelli WP, Levy D. Cholesterol and mortality: 30 years of follow-up from the Framingham Study. JAMA 1987;257:2176–2180.
2. The Expert Panel. Report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults. Arch Intern Med 1988;148:36–39.
3. Brown BG, Albers JJ, Fisher LD, Schaefer SM, Jiin-Tarng L, Kaplan C, Zhao XQ, Bisson BD, Fitzpatrick VF, Dodge HT. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. New Engl J Med 1990;323(19):1289–1298.
4. Buchwald H, Vargo RL, Matts JP, Long JM, Fitch LL, Campbell GS, Pearce MB, Yellin AE, Edmiston WA, Smink RD Jr, et al. Effect of partial ilial bypass on mortality and morbidity from coronary artery disease in patients with hypercholesterolemia–Report of the Program on Surgical Control of the Hyperlipidemia (POSCH). New Engl J Med 1990;323:946.
5. Watts GF, Lewis B, Brunt NH,Lewis ES, Coltart DJ, Smith LDR, Mann JI, Swan AV. Effects on coronary artery disease of lipid lowering diet, or diet plus cholestyramine, in the St. Thomas' atherosclerosis regression study (STARS). Lancet 1992;339:563–569.
Cited by 120 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Hypercholesterolemia: a literature review on management using tafolecimab: a novel member of PCSK9 monoclonal antibodies;Annals of Medicine & Surgery;2024-03-12
2. Comparison of the efficacy and safety of Shanhuang Jiangzhi tablets and atorvastatin in the treatment of patients with hyperlipidaemia;Journal of Health, Population and Nutrition;2023-12-14
3. Simvastatin: In Vitro Metabolic Profiling of a Potent Competitive HMG-CoA Reductase Inhibitor;Separations;2022-11-30
4. Prevalence of statin intolerance: a meta-analysis;European Heart Journal;2022-02-16
5. Clinical strategies for reducing cholesterol levels;Cholesterol;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3